Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

But they disagree on whether studying social genomics—elucidating any potential genetic contributions to behaviors ranging from mental illnesses to educational attainment to political affiliation—can ...

For each card, stay on top of its benefits, give it a purpose and keep it on you only if you need it 'in the wild.' Many or all of the products on this page are from partners who compensate us when ...